 
|
 |
   
- Geldmacher, D.S. and Whitehouse, P.J. Evaluation of Dementia. New England Journal of Medicine 1996; 335(5):330-336.
- Statistics/Prevalence. Alzheimer's Association. www.alz.org/hc/overview/stats.htm 1999.
- Corder, E.H. et al., Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families. Science 1993; 261:921-923.
- Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease." The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiology of Aging 1998; 19(2):109-116.
- Soininen, H. et al., A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer's patients carrying apolipoprotein epsilon 4 allele. Neuroscience Letter 1995; 187(2):79-82.
- Riekkinen, P.J. and Soininen, H.S. Apolipoprotein E and Temporal Lobe Pathology: Magnetic Resonance Imaging and Population-based Studies. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics, ed. K. Iqbal et al., 145-148. 1997. Chichester: John Wiley & Sons.
- Mayeux, R. et al., Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease. The New England Journal of Medicine 1998; 338:506-511.
- Clark, M. et al., Variability in Annual Mini-Mental Status Examination Scores in Patients with Probable Alzheimer's Disease. Archives of Neurology 1999; 56:857-862.
- Craft, S. et al., Accelerated decline in apoE e4 homozygotes with Alzheimer's disease. Neurology 1998; 51:149-153.
|
